Download PDF
Neuropediatrics 2021; 52(03): 186-191
DOI: 10.1055/s-0040-1721686
Original Article

Two Missense CACNA1A Variants in a Single Family with Variable Neurobehavioral, Cerebellar, Epileptic, and Oculomotor Features

Pin-Yi Ko
1   Division of Pediatric Neurology, Department of Neurology, University of Washington, Seattle, Washington, United States
,
Ian A. Glass
2   Center for Integrative Brain Research, Seattle, Washington, United States
3   Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, Washington, United States
4   Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington, United States
,
Suzanne Crandall
5   Department of Neurology, Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States
,
Avery Weiss
6   Department of Ophthalmology, University of Washington, Seattle, Washington, United States
,
Michael O. Dorschner
4   Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington, United States
,
John P. Kelly
6   Department of Ophthalmology, University of Washington, Seattle, Washington, United States
,
James O. Phillips
7   Department of Otolaryngology-HNS, University of Washington, Seattle, Washington, United States
,
Jonathan Lopez
1   Division of Pediatric Neurology, Department of Neurology, University of Washington, Seattle, Washington, United States
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

We describe two novel missense variants in CACNA1A segregating in a family with variable severity of ataxia/oculomotor dysfunction, neurobehavioral impairments, and epilepsy. The most severe outcome occurred in a compound heterozygous proband, which could represent variable expression of the paternal allele or biallelic modulation of calcium channel function. Acetazolamide and lamotrigine were effective for seizure control.

Keywords

epilepsy - ataxia - oculomotor - neurobehavioral - CACNA1A


Publication History

Received: 15 May 2020

Accepted: 10 September 2020

Article published online:
14 January 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Kordasiewicz HB, Thompson RM, Clark HB, Gomez CM. C-termini of P/Q-type Ca2+ channel alpha1A subunits translocate to nuclei and promote polyglutamine-mediated toxicity. Hum Mol Genet 2006; 15 (10) 1587-1599
    CrossrefPubMedGoogle Scholar
  • 2 Jiang X, Raju PK, D'Avanzo N. et al. Both gain-of-function and loss-of-function de novo CACNA1A mutations cause severe developmental epileptic encephalopathies in the spectrum of Lennox-Gastaut syndrome. Epilepsia 2019; 60 (09) 1881-1894
    CrossrefPubMedGoogle Scholar
  • 3 Kersten HM, Roxburgh RH, Danesh-Meyer HV. Ophthalmic manifestations of inherited neurodegenerative disorders. Nat Rev Neurol 2014; 10 (06) 349-362
    CrossrefPubMedGoogle Scholar
  • 4 Weiss AH, Kelly JP, Hopper RA, Phillips JO. Crouzon Syndrome: relationship of eye movements to pattern strabismus. Invest Ophthalmol Vis Sci 2015; 56 (08) 4394-4402
    CrossrefPubMedGoogle Scholar
  • 5 Kelly JP, Baran F, Phillips JO, Weiss AH. Optical coherence tomography in optic nerve hypoplasia: correlation with optic disc diameter, thickness, and visual function. J Neuroophthalmol 2018; 38 (03) 312-319
    CrossrefPubMedGoogle Scholar
  • 6 Karczewski KJ, Francioli LC, Tiao G. et al; Genome Aggregation Database Consortium. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 2020; 581 (7809): 434-443
    CrossrefPubMedGoogle Scholar
  • 7 Landrum MJ, Lee JM, Benson M. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res 2018; 46 (D1): D1062-D1067
    CrossrefPubMedGoogle Scholar
  • 8 Richards S, Aziz N, Bale S. et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
    CrossrefPubMedGoogle Scholar
  • 9 Angelini C, Van Gils J, Bigourdan A. et al. Major intra-familial phenotypic heterogeneity and incomplete penetrance due to a CACNA1A pathogenic variant. Eur J Med Genet 2019; 62 (06) 103530 DOI: 10.1016/j.ejmg.2018.08.01.
    CrossrefPubMedGoogle Scholar
  • 10 Barros J, Damásio J, Tuna A. et al. Cerebellar ataxia, hemiplegic migraine, and related phenotypes due to a CACNA1A missense mutation: 12-year follow-up of a large Portuguese family. JAMA Neurol 2013; 70 (02) 235-240
    CrossrefPubMedGoogle Scholar
  • 11 Damaj L, Lupien-Meilleur A, Lortie A. et al. CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms. Eur J Hum Genet 2015; 23 (11) 1505-1512
    CrossrefPubMedGoogle Scholar
  • 12 Smith RS, Walsh CA. Ion channel functions in early brain development. Trends Neurosci 2020; 43 (02) 103-114
    CrossrefPubMedGoogle Scholar
  • 13 Rossignol E, Kruglikov I, van den Maagdenberg AM, Rudy B, Fishell G. CaV 2.1 ablation in cortical interneurons selectively impairs fast-spiking basket cells and causes generalized seizures. Ann Neurol 2013; 74 (02) 209-222
    CrossrefPubMedGoogle Scholar
  • 14 Reinson K, Õiglane-Shlik E, Talvik I. et al. Biallelic CACNA1A mutations cause early onset epileptic encephalopathy with progressive cerebral, cerebellar, and optic nerve atrophy. Am J Med Genet A 2016; 170 (08) 2173-2176
    CrossrefPubMedGoogle Scholar
  • 15 Tantsis EM, Gill D, Griffiths L. et al. Eye movement disorders are an early manifestation of CACNA1A mutations in children. Dev Med Child Neurol 2016; 58 (06) 639-644
    CrossrefPubMedGoogle Scholar
  • 16 Kipfer S, Jung S, Lemke JR. et al. Novel CACNA1A mutation(s) associated with slow saccade velocities. J Neurol 2013; 260 (12) 3010-3014
    CrossrefPubMedGoogle Scholar
  • 17 Indelicato E, Nachbauer W, Karner E. et al. The neuropsychiatric phenotype in CACNA1A mutations: a retrospective single center study and review of the literature. Eur J Neurol 2019; 26 (01) 66-e7
    CrossrefPubMedGoogle Scholar
  • 18 Byers HM, Beatty CW, Hahn SH, Gospe Jr SM. Dramatic response after lamotrigine in a patient with epileptic encephalopathy and a de novo CACNA1A variant. Pediatr Neurol 2016; 60: 79-82
    CrossrefPubMedGoogle Scholar
  • 19 Battistini S, Stenirri S, Piatti M. et al. A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology 1999; 53 (01) 38-43
    CrossrefPubMedGoogle Scholar
  • 20 Scoggan KA, Friedman JH, Bulman DE. CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acid. Can J Neurol Sci 2006; 33 (01) 68-72
    CrossrefPubMedGoogle Scholar
  • 21 Kotagal V. Acetazolamide-responsive ataxia. Semin Neurol 2012; 32 (05) 533-537
    PubMedGoogle Scholar
  • 22 Mefford HC. Clinical genetic testing in epilepsy. Epilepsy Curr 2015; 15 (04) 197-201
    CrossrefPubMedGoogle Scholar
  • 23 Rash BG, Ackman JB, Rakic P. Bidirectional radial Ca(2+) activity regulates neurogenesis and migration during early cortical column formation. Sci Adv 2016; 2 (02) e1501733
    CrossrefPubMedGoogle Scholar
  • 24 Rakic P, Komuro H. The role of receptor/channel activity in neuronal cell migration. J Neurobiol 1995; 26 (03) 299-315
    CrossrefPubMedGoogle Scholar